Archean Chemical

The Indian chemical market remains strong with over 80,000 commercial products. Despite global headwinds^🌐 and demand variations from key global markets, Indian chemical manufacturers, including Archean, have shown resilience and improved operational performance. While signs of recovery are appearing in the global chemical industry, geopolitical challenges persist, and the recovery is expected to be uneven across geographies and sectors. Archean is observing consistent client demand for its key products, reflected in its Q4 FY25 performance.

Elemental Bromine contributed approximately one-third of total revenue in FY25, with Archean remaining India's largest exporter. Contracted volumes were in line with the prior year, and the company targets 22,000 to 25,000 tons for FY26, including captive consumption. Industrial Salt accounted for almost two-thirds of total revenue, with Q4 volumes recovering to 1.3 million tons. Operational challenges related to logistics were addressed by adding a dedicated fleet. Capacity has expanded to over 5 million tons annually, with quarterly run rates expected to remain above 1 million tons, supported by long-term customer relationships.

Bromine Derivatives operations are currently at 20-30% capacity utilization, contributing to Q4 FY25 performance through clear brine fluids and PTA catalysts. Utilization is expected to rise above 50% in the near term, with exports already commenced. The company has invested INR 160-170 crores in this platform, with an overall project cost of INR 250 crores. Sulphate of Potash (SOP) trials are promising, with plant-scale demonstration expected in the next quarter and meaningful contributions anticipated from H2 FY26. Archean remains one of the few global manufacturers of SOP.

The acquisition of Oren Hydrocarbon in 2024 is progressing, with two facilities in Andhra Pradesh now ready for operations. The remaining units in Gujarat and Tamil Nadu are expected to commence operations towards the latter part of FY26. The company expects Oren Hydrocarbon to contribute approximately INR 150 crores in revenue during FY26. The acquisition cost was around INR 77 crores, with an additional INR 10 crores spent on refurbishment. Historically, Oren Hydrocarbon had achieved nearly INR 500 crores in top-line revenue.

Archean is pursuing two new strategic initiatives. The semiconductor manufacturing initiative has completed the land acquisition process and submitted its application to the Indian semiconductor mission, awaiting final approval from the central government. Capex for this project is estimated at INR 50-60 crores for the current year. In the energy storage battery business, the company's investment in Offgrid Energy Labs, a US-based zinc-bromide battery innovator, is progressing well, with the pilot plant in the UK expected to start up in the coming quarter.

The company maintains a net debt-free status, with a net debt to equity ratio of 0.03 for FY25, supported by a strong balance sheet. The Board has recommended a final dividend of INR 3 per equity share for the financial year ending March 31, 2025. Investments in the Bromine Derivatives platform total INR 160-170 crores out of an overall project cost of INR 250 crores, with the balance allocated to the flame retardant project. Additional capex includes INR 20-30 crores for SOP plant start-up and INR 50-60 crores for the semiconductor project this year.